Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Ferguson

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Circulation|March 1, 1994
Meeting highlights: 66th scientific sessions of the American Heart Association, Atlanta, Ga., November 8-11, 1993J J Ferguson
Circulation|July 1, 1996
American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996J J Ferguson
Circulation|June 26, 1998
Meeting highlights: 47th Annual Scientific Sessions of the American College of CardiologyJ J Ferguson
Family Practice|December 1, 1988
Introductory course in medical English and primary care for overseas doctorsJ J Ferguson, J MacLean
American Heart Journal|July 30, 1999
IIb/IIIa receptor blockade in acute myocardial infarctionJ J Ferguson, K Taqi
Journal of the American College of Cardiology|March 15, 1994
Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplastyA Avendaño, J J Ferguson
Annals of the New York Academy of Sciences|January 1, 1980
Direct photoaffinity labeling of phosphofructokinase using adenosine derivativesJ J Ferguson, M MacInnes
Vnitrni Lekarstvi|July 1, 1993
[Visual and quantitative evaluation of coronarography findings in patients with percutaneous transluminal coronary angiography]M Aschermann, J J Ferguson
Expert Opinion on Investigational Drugs|January 5, 2002
Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarctionJ J Ferguson, D Vaisman
Drugs|January 29, 2000
Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directionsJ J Ferguson, M Zaqqa
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Circulation|March 1, 1994
Meeting highlights: 66th scientific sessions of the American Heart Association, Atlanta, Ga., November 8-11, 1993J J Ferguson
Circulation|July 1, 1996
American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996J J Ferguson
Circulation|June 26, 1998
Meeting highlights: 47th Annual Scientific Sessions of the American College of CardiologyJ J Ferguson
Family Practice|December 1, 1988
Introductory course in medical English and primary care for overseas doctorsJ J Ferguson, J MacLean
American Heart Journal|July 30, 1999
IIb/IIIa receptor blockade in acute myocardial infarctionJ J Ferguson, K Taqi
Journal of the American College of Cardiology|March 15, 1994
Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplastyA Avendaño, J J Ferguson
Annals of the New York Academy of Sciences|January 1, 1980
Direct photoaffinity labeling of phosphofructokinase using adenosine derivativesJ J Ferguson, M MacInnes
Vnitrni Lekarstvi|July 1, 1993
[Visual and quantitative evaluation of coronarography findings in patients with percutaneous transluminal coronary angiography]M Aschermann, J J Ferguson
Expert Opinion on Investigational Drugs|January 5, 2002
Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarctionJ J Ferguson, D Vaisman
Drugs|January 29, 2000
Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directionsJ J Ferguson, M Zaqqa
Pageof 15